Medidata Stock Hits New 52-Week High (MDSO)

NEW YORK ( TheStreet) -- Medidata Solutions (Nasdaq: MDSO) hit a new 52-week high Tuesday as it is currently trading at $28.93, above its previous 52-week high of $27.96 with 219,471 shares traded as of 10:15 a.m. ET. Average volume has been 284,400 shares over the past 30 days.

Medidata has a market cap of $637.2 million and is part of the technology sector and computer software & services industry. Shares are up 19.1% year to date as of the close of trading on Monday.

Medidata Solutions, Inc. provides software-as-a-service based clinical development solutions for life science organizations worldwide. The company has a P/E ratio of 15.8, equal to the average computer software & services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medidata as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Medidata Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.